查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1917788

鷹架技術市場－2026-2031年預測

Scaffold Technology Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 152 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計鷹架技術市場將從 2025 年的 17.86 億美元成長到 2031 年的 33.04 億美元，複合年成長率為 10.8%。

支架技術市場正迅速發展，這主要得益於再生醫學的日益普及和組織工程領域的創新。奈米纖維支架因其在神經和組織再生等先進應用方面的潛力而備受關注。各公司正在開發客製化的3D生物列印支架，以改善組織修復並加速藥物測試。政府的資金支持和監管措施也有助於加快生物醫學醫療設備的核准。

支架技術能夠建構模擬細胞外基質的3D結構，為組織工程和再生醫學中的細胞黏附、生長和分化提供機械支撐和有利環境。這些多孔結構由多種生物材料製成，可引導組織形成，同時促進營養物質擴散和代謝廢物清除。在藥物研發中，支架可作為建構化合物庫的分子基礎。受對3D細胞模型、微創解決方案和慢性病管理的需求驅動，該市場正穩步擴張。

推動3D細胞培養系統成長要素的關鍵因素是生物學和轉化研究中對3D細胞培養系統日益成長的需求，這克服了傳統2D模型在藥物開發和疾病建模方面的限制。3D細胞培養中支架的廣泛應用能夠建構生理相關的微環境，從而提高細胞活力、功能性和預測準確性。靜電紡絲、溶劑澆鑄、顆粒洗脫、氣體發泡、纖維網、微影和自組裝等製造技術的進步，正在提升支架的結構精度、孔隙率和生物相容性。在癌症治療領域，3D腫瘤模型（採用生物相容性聚合物）和免疫治療平台的應用不斷拓展，這些模型能夠重現微環境訊號，從而提高療效評估的準確性。尤其值得一提的是，奈米纖維支架憑藉其靜電紡絲的高比表面積、模擬細胞外基質的特性、成本效益和多功能性，已在神經再生領域佔據了顯著的市場佔有率。

隨著專業應用的擴展以及與先進成像技術的整合，能夠從患者掃描中自動生成模型，新的機會正在湧現。

從區域上看，北美預計將實現強勁成長，這得益於活躍的幹細胞和再生醫學研究、充足的資金籌措、完善的醫療基礎設施以及在微支架創新方面的技術領先地位。

主要企業包括賽默飛世爾科技、默克公司、ReproCELL公司、3D Biotech公司和貝克頓·迪金森公司。這些公司憑藉其生物材料專業知識、製造平台和整形外科解決方案（包括水凝膠、聚合物和陶瓷支架），推動生物材料的進步，這些解決方案適用於骨科、心血管、神經和腫瘤再生。

總體而言，隨著慢性疾病和器官短缺帶來的挑戰，對患者特異性功能性組織構建體的需求不斷成長，市場正在穩步發展，並有望透過先進的仿生技術、精密製造和臨床應用效果來改變再生醫學。

本報告的主要優勢：

  • 深入分析：提供對主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
  • 競爭格局：了解全球主要參與者的策略舉措，並了解透過正確的策略進入市場的機會。
  • 市場促進因素與未來趨勢：分析市場促進因素和關鍵趨勢及其對未來市場發展的影響。
  • 可操作的建議：利用這些見解，在快速變化的環境中做出策略決策，並發現新的商機和收入來源。
  • 受眾廣泛：適用於Start-Ups、研究機構、顧問公司、中小企業和大型企業，且經濟實惠。

企業如何使用我們的報告？

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

研究範圍：

  • 2021年至2025年的歷史數據和2026年至2031年的預測數據
  • 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 按業務板塊和地區（包括國家）分類的收入和預測評估
  • 公司概況（策略、產品、財務資訊、關鍵發展等）

目錄

第1章執行摘要

第2章 市場概覽

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策與法規
  • 策略建議

第4章 技術展望

5. 支架技術市場（依產品類型分類）

  • 介紹
  • 水凝膠
  • 聚合物支架
  • 微圖案化表面微孔盤
  • 奈米纖維支架

6. 支架技術市場（依材料分類）

  • 介紹
  • 自然的
  • 合成

7. 按應用分類的鷹架技術市場

  • 介紹
  • 組織工程
  • 藥物發現
  • 其他

8. 依最終用戶分類的鷹架技術市場

  • 介紹
  • 醫院和診所
  • 製藥和生物技術公司
  • 學術和研究機構

9. 各地區鷹架技術市場

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第10章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 合併、收購、協議和合作
  • 競爭對手儀錶板

第11章 公司簡介

  • Thermo Fisher Scientific, Inc.
  • REPROCELL Inc.
  • 3D Biotek LLC
  • Becton, Dickinson, and Company
  • Medtronic Plc
  • Matricel GmbH
  • Vericel Corporation
  • ACRO Biomedical Co., Ltd
  • Corning Incorporated
  • Ilex Life Sciences

第12章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061615761

Scaffold Technology Market, with a 10.8% CAGR, is expected to grow to USD 3.304 billion in 2031 from USD 1.786 billion in 2025.

The scaffold technology market is advancing rapidly, driven by increasing adoption in regenerative medicine and tissue engineering innovations. Nanofiber scaffolds are gaining traction for sophisticated applications in nerve and tissue regeneration. Companies are developing customized 3D-bioprinted scaffolds to improve tissue repair efficacy and accelerate drug testing. Government support through funding and regulatory pathways is bolstering biomedical device approvals.

Scaffold technology provides three-dimensional constructs that mimic the extracellular matrix, offering mechanical support and a conducive environment for cell adhesion, proliferation, and differentiation in tissue engineering and regenerative medicine. These porous structures, fabricated from diverse biomaterials, facilitate nutrient diffusion and waste removal while guiding tissue formation. In drug discovery, scaffolds serve as molecular frameworks for compound library generation. The market is expanding steadily, fueled by demand for 3D cellular models, minimally invasive solutions, and chronic disease management.

Key growth drivers include the escalating need for 3D cell culture systems in biological research and translational studies, addressing limitations in traditional 2D models for drug development and disease modeling. Rising utilization of scaffolds in 3D cell culture enables physiologically relevant microenvironments, enhancing viability, functionality, and predictive accuracy. Advancements in fabrication techniques-such as electrospinning, solvent casting, particle leaching, gas foaming, fiber meshing, lithography, and self-assembly-improve structural precision, porosity, and biocompatibility. Increasing application in cancer treatment leverages biocompatible polymers for 3D tumor models and immunotherapy platforms, recapitulating microenvironmental cues for better therapeutic evaluation. Nanofiber scaffolds are capturing significant share due to high surface-to-volume ratios and extracellular matrix mimicry, particularly via electrospinning for affordability and versatility in nerve regeneration.

Opportunities emerge from broadening specialty applications and integrating with advanced imaging for automated model generation from patient scans.

Geographically, North America is anticipated for steady growth, supported by robust stem cell and regenerative medicine research, substantial funding, established healthcare infrastructure, and technological leadership in micro-scaffold innovations.

Leading companies include Thermo Fisher Scientific, Inc., Merck KGaA, REPROCELL Inc., 3D Biotek LLC, and Becton, Dickinson, and Company. These firms drive progress through biomaterial expertise, fabrication platforms, and integrated solutions spanning hydrogel, polymeric, and ceramic scaffolds tailored for orthopedic, cardiovascular, neural, and oncologic regeneration.

Overall, the market is progressing consistently, positioned to transform regenerative therapies through enhanced biomimicry, precision fabrication, and translational efficacy, as demand intensifies for patient-specific, functional tissue constructs amid chronic disease and organ shortage challenges.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Scaffold Technology Market Segmentation

  • By Product Type
  • Hydrogels
  • Polymeric Scaffolds
  • Micropatterned Surface Microplates
  • Nanofibrous Scaffolds
  • By Material
  • Natural
  • Synthetic
  • By Application
  • Tissue Engineering
  • Drug Discovery
  • Others
  • By End-User
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Company
  • Academic & Research Institutes
  • By Geography
  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. SCAFFOLD TECHNOLOGY MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Hydrogels
  • 5.3. Polymeric Scaffolds
  • 5.4. Micropatterned Surface Microplates
  • 5.5. Nanofibrous Scaffolds

6. SCAFFOLD TECHNOLOGY MARKET BY MATERIAL

  • 6.1. Introduction
  • 6.2. Natural
  • 6.3. Synthetic

7. SCAFFOLD TECHNOLOGY MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Tissue Engineering
  • 7.3. Drug Discovery
  • 7.4. Others

8. SCAFFOLD TECHNOLOGY MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals & Clinics
  • 8.3. Pharmaceutical & Biotechnology Company
  • 8.4. Academic & Research Institutes

9. SCAFFOLD TECHNOLOGY MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Israel
    • 9.5.4. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Thermo Fisher Scientific, Inc.
  • 11.2. REPROCELL Inc.
  • 11.3. 3D Biotek LLC
  • 11.4. Becton, Dickinson, and Company
  • 11.5. Medtronic Plc
  • 11.6. Matricel GmbH
  • 11.7. Vericel Corporation
  • 11.8. ACRO Biomedical Co., Ltd
  • 11.9. Corning Incorporated
  • 11.10. Ilex Life Sciences

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations